Antimicrobial Susceptibility Testing Market Analysis and Global Forecast 2023-2033

Antimicrobial Susceptibility Testing Market Overview

The Antimicrobial Susceptibility Testing Market Size is expected to reach USD 8.41 Billion by 2033. The Antimicrobial Susceptibility Testing industry size accounted for USD 3.62 Billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2033. The antimicrobial susceptibility testing market involves diagnostic technologies used to determine the effectiveness of antibiotics and other antimicrobial agents against pathogens. This market is driven by the increasing prevalence of infectious diseases and the rise of antibiotic-resistant strains. Key segments include disc diffusion, broth microdilution, and automated systems. The market encompasses various applications in hospitals, diagnostic laboratories, and research institutions. Growth is supported by advancements in technology, increasing awareness of antimicrobial stewardship, and rising healthcare expenditures. Major players include companies specializing in diagnostic instruments and reagents.

Global Antimicrobial Susceptibility Testing Market Synopsis

COVID-19 Impact Analysis

The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the antimicrobial susceptibility testing market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers to adopt various strategies to stabilize the company.

Antimicrobial Susceptibility Testing Market Dynamics

The major factors that have impacted the growth of Antimicrobial Susceptibility Testing are as follows:

Drivers:

Ø  Technological Advancements

Innovations in diagnostic technologies, such as automated AST systems and high-throughput screening methods, have improved the accuracy and efficiency of susceptibility testing. These advancements drive market growth by providing faster results and more comprehensive data.

Restraint:

• High Costs of Advanced Technologies

The cost of advanced AST technologies, such as automated systems and high-throughput platforms, can be prohibitively high for many healthcare facilities, especially in developing regions. This limits their accessibility and adoption, constraining market growth.

Opportunity:

⮚      Increased Government and Public Health Initiatives

Governments and international organizations are intensifying efforts to combat antimicrobial resistance through various initiatives and funding programs. Support for research, development, and deployment of AST technologies can drive market growth and innovation.

Antimicrobial Susceptibility Testing Segment Overview

By Product Type

Based on Product Type, the market is segmented based on Instruments, Consumables & Accessories, Services & Software Others. clinical diagnostics dominates due to its critical role in guiding effective treatment decisions for infectious diseases in healthcare settings.

By Application

Based on Applications, the market has been divided into the Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others. clinical diagnostics dominates due to its critical role in guiding effective treatment decisions for infectious diseases in healthcare settings.

Global Antimicrobial Susceptibility Testing Market Regional Analysis

Based on region, the global Antimicrobial Susceptibility Testing market has been divided into North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America. North America is projected to dominate the use of the Antimicrobial Susceptibility Testing market followed by the Asia-Pacific and Europe regions.

Antimicrobial Susceptibility Testing North America Market

North America holds a dominant position in the Antimicrobial Susceptibility Testing Market. In North America, the antimicrobial susceptibility testing (AST) market is driven by advanced healthcare infrastructure, high prevalence of infectious diseases, and robust research and development activities. The region benefits from significant investments in diagnostic technologies and a strong emphasis on combating antimicrobial resistance. The presence of major diagnostic companies and high healthcare expenditure further supports market growth.

Antimicrobial Susceptibility Testing Asia-Pacific Market

The Asia-Pacific region has indeed emerged as the fastest-growing market for the Antimicrobial Susceptibility Testing industry. In the Asia-Pacific region, the antimicrobial susceptibility testing (AST) market is growing rapidly due to rising healthcare investments, increasing incidences of infectious diseases, and expanding healthcare infrastructure. The region’s large population base and high burden of antimicrobial resistance drive demand for effective AST solutions. Additionally, government initiatives and growing awareness of antimicrobial stewardship contribute to market growth.

Competitive Landscape

The global Antimicrobial Susceptibility Testing market is highly competitive, with numerous players offering a wide range of software solutions. The competitive landscape is characterized by the presence of established companies, as well as emerging startups and niche players. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as product launches, and strategic alliances.

Prominent Players:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• BioMérieux S.A.
• Becton
• MERLIN Diagnostika GmbH
• Accelerate Diagnostics, Inc.
• Alifax S.r.l.
• Creative Diagnostics
• SYNBIOSIS

Key Development

In September 2022, Thermo Fisher Scientific Inc. launched the Thermo Scientific™ Sensititre™ 8-Panel AST System, enhancing antimicrobial susceptibility testing with a comprehensive, automated solution for faster and more accurate results.

Scope of the Report

Global Antimicrobial Susceptibility Testing Market, by Product

• Instruments
• Consumables & Accessories
• Services & Software
• Others

 Global Antimicrobial Susceptibility Testing Market, by Application

• Clinical Diagnostics
• Drug Discovery and Development
• Epidemiology

 Global Antimicrobial Susceptibility Testing Market, by Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Benelux
  • Nordic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Indonesia
  • Austalia
  • Malaysia
  • India
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

 

Parameters	Indicators
Market Size	2033: $8.41 Billion
CAGR	7.5% CAGR (2023-2033)
Base year	2022
Forecast Period	2023-2033
Historical Data	2021
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations	Product Type, Application
Geographies Covered	North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors	Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., BioMérieux S.A., Becton, MERLIN Diagnostika GmbH, Accelerate Diagnostics, Inc., Alifax S.r.l., Creative Diagnostics, SYNBIOSIS
Key Market Opportunities	• The rise of e-commerce
Key Market Drivers	• Technological Advancements • Increasing Urbanization

 

REPORT CONTENT BRIEF:

• High-level analysis of the current and future Antimicrobial Susceptibility Testing market trends and opportunities
• Detailed analysis of current market drivers, restraining factors, and opportunities in the future
• Antimicrobial Susceptibility Testing market historical market size for the year 2021, and forecast from 2023 to 2033
• Antimicrobial Susceptibility Testing market share analysis at each product level
• Competitor analysis with detailed insight into its product segment, Government & Defense strength, and strategies adopted.
• Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
• To identify and understand the various factors involved in the global Antimicrobial Susceptibility Testing market affected by the pandemic
• To provide a detailed insight into the major companies operating in the market. The profiling will include the Government & Defense health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.